160,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Connectomic Medicine: A Guide to Brain AI in Treatment Decision Planning examines how to apply connectomics to clinical medicine, including discussions on techniques, applications, novel ideas, and in case examples that highlight the state-of-the-art. Written by pioneers, this volume serves as the foundation for all neuroscience clinicians/researchers venturing into the field of AI medicine, its realistic applications, and how to integrate AI connectomics into clinical practice. With widespread applications in neurology, neurosurgery and psychiatry, this book is appropriate for anyone…mehr

Produktbeschreibung
Connectomic Medicine: A Guide to Brain AI in Treatment Decision Planning examines how to apply connectomics to clinical medicine, including discussions on techniques, applications, novel ideas, and in case examples that highlight the state-of-the-art. Written by pioneers, this volume serves as the foundation for all neuroscience clinicians/researchers venturing into the field of AI medicine, its realistic applications, and how to integrate AI connectomics into clinical practice. With widespread applications in neurology, neurosurgery and psychiatry, this book is appropriate for anyone interested in cerebral network anatomy, imaging techniques, and insights into this emerging field.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Sughrue is Associate Professor at the Department of Neurosurgery at Prince of Wales Hospital and Community Health Services in Sydney, Australia. One of the world's leading neurosurgeons and researchers in connectomics, he is the former Director of the Brain Tumor Center at the University of Oklahoma, during which it grew to become one of the largest clinics in the US. He has lectured around the world on the management of glioma and the use of connectomics, having performed over 3,000 brain tumor surgeries to date and published over 250 peer-reviewed articles. In addition, he cofounded Omniscient Neurotechnology which is an innovative technology startup aimed at using AI to improve the care of patients with mental illness and brain disease.